Results
1 -
10 of
28Kohlhoff Stephan A, Sharma Roopali.
Iclaprim, Expert Opinion on Investigational Drugs, 2007 Morgan Andrew, Cofer Christine, Stevens Dennis L.
Iclaprim: a novel dihydrofolate reductase inhibitor for skin and soft tissue infections, Future Microbiology, 2009 Schneider Peter, Hawser Stephen, Islam Khalid.
Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria, Bioorganic & Medicinal Chemistry Letters, 2003 Neue Antibiotika: Schritt- oder Sprunginnovationen?, Der Internist Therapeutic options for the treatment of infections with multiresistant grampositive bacteria in oncological patients, memo - Magazine of European Medical Oncology Pathogens in Severe Sepsis: New Paradigms for Gram-Positive Treatment, Sepsis Management Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unit, Critical Care The Search for New Antibacterial Drugs, Pharmaceutical Innovation Viscous Flow Computations Using a Meshless Solver, LSFD-U, Computational Fluid Dynamics 2004 Application of SBDD to the Discovery of New Antibacterial Drugs, Structure-Based Drug Discovery